about
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel c...
Read More
59.29
1.04
(1.79%)
1.4M
XNAS Volume
XNAS 06 Mar, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Vaxcyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..